capecitabine has been researched along with Anterior Horn Cell Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hanssen, H; Heldmann, M; Münte, TF; Wagner-Altendorf, TA | 1 |
Bergin, P; Damianovich, D; Findlay, M; Hanning, F; Hill, A; McKeage, MJ; Thompson, P | 1 |
2 other study(ies) available for capecitabine and Anterior Horn Cell Disease
Article | Year |
---|---|
Permanent lesion to the corticospinal tract after therapy with capecitabine.
Topics: Antimetabolites, Antineoplastic; Capecitabine; Colorectal Neoplasms; Diagnosis, Differential; Fatal Outcome; Humans; Leukoencephalopathies; Magnetic Resonance Imaging; Male; Middle Aged; Motor Neuron Disease; Pneumonia, Aspiration; Pyramidal Tracts; Quadriplegia | 2019 |
Detecting acute neurotoxicity during platinum chemotherapy by neurophysiological assessment of motor nerve hyperexcitability.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carboplatin; Cisplatin; Colorectal Neoplasms; Deoxycytidine; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Motor Neuron Disease; Neoplasm Staging; Neurophysiology; Neurotoxicity Syndromes; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Retrospective Studies; Survival Rate; Treatment Outcome | 2010 |